Wordt geladen...
Novel paradigm for immunotherapy of breast cancer by engaging prophylactic immunity against hepatitis B
BACKGROUND: Immunotherapy of patients suffering from the human epidermal growth factor receptor 2 overexpressing (HER-2(+)) breast cancers with the anti-HER-2 antibodies results in increase of the patients’ overall survival. However, no prophylactic vaccine is available against HER-2(+) breast cance...
Bewaard in:
| Gepubliceerd in: | Clin Transl Med |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer Berlin Heidelberg
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4990520/ https://ncbi.nlm.nih.gov/pubmed/27539579 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40169-016-0111-8 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|